Table 4.
Group | Injury Incidence (%) | GUI-1 * (% of Area) |
Inhibition of GUI-1^ (%) | GUI-2$ (Point) |
Inhibition of GUI-2^ (%) |
---|---|---|---|---|---|
Control | 0 | 0 ± 0a | - | 1.5 ± 0.8a | - |
Model | 100% | 14.36 ± 8.92d | 0 | 67.4 ± 12.7d | 0 |
Sucralfate | 90% | 1.54 ± 1.46a,b | 89.3 | 14.7 ± 11.2a,b | 78.3 |
BCM | 90% | 7.73 ± 4.10c | 46.2 | 37.7 ± 25.7c | 44.2 |
L-Se | 100% | 5.72 ± 2.04b,c | 60.2 | 34.3 ± 18.9b,c | 49.2 |
M-Se | 100% | 2.50 ± 1.75a,b | 82.6 | 14.1 ± 8.4a,b | 79.1 |
H-Se | 100% | 2.03 ± 1.72a,b | 85.8 | 20.4 ± 14.0a,b,c | 69.8 |
Notes: a–dMeans within a column with different letters differ significantly (P < 0.05). *The score was grading in accordance with Reference.28 $The score was grading based on the criteria listed in Reference.6 ^The percentage of ulcer inhibition was calculated as the formula: (GUIModel - GUIexperimental group)/GUIModel × 100%.